Advair Diskus 250 [Fluticasone Propionate + Salmeterol inhalation powder 250mcg | 50mcg x 60 doses] CANADIAN PHARMACEUTICAL GRADE

Description

Advair Diskus 250 [Fluticasone Propionate + Salmeterol Inhalation Powder 250mcg | 50mcg x 60 Doses] – Canadian Pharmaceutical Grade

Advair Diskus 250 is a combination research inhalation system containing Fluticasone Propionate (250mcg) and Salmeterol Xinafoate (50mcg) per dose. It is studied for its dual action on glucocorticoid receptor-mediated anti-inflammatory responses and beta-2 adrenergic receptor activation within pulmonary research applications.

This formulation provides a dry powder delivery mechanism for consistent, metered dosing in laboratory models exploring airway receptor signaling and combined corticosteroid–beta-agonist dynamics.

Each Diskus device delivers 60 precisely measured doses and is manufactured to Canadian pharmaceutical-grade standards. Every unit undergoes independent verification to ensure potency, uniformity, and composition integrity.

Continue your advanced research at: True North Performance